Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 4/20 | 0.56 |
| ▸ | TP53 | P04637 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | PGR | P06401 | 10/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | KDR | P35968 | 1/20 | 0.48 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.48 |
| ▸ | BRD4 | O60885 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6982218 | 0.86 | PKM (0.56) | PKMLMNAMAPT | |
| SCHEMBL6984820 | 0.86 | HTR6 (0.61) | PKMTP53LMNAMAPTBRD4 | |
| SCHEMBL6974134 | 0.86 | HSD17B2 (0.50) | PKMLMNAPGRKDRAURKB | |
| SCHEMBL10959038 | 0.83 | PKM (0.58) | PKMTP53LMNAMAPTPGR | |
| Hydrochloric Acid SCHEMBL10957321 | 0.82 | PKM (0.57) | PKMTP53LMNAMAPTPGR | |
| SCHEMBL11948477 | 0.81 | CYP3A4 (0.51) | PKMPGR | |
| SCHEMBL6976538 | 0.81 | PKM (0.65) | PKMLMNAMAPTPGRBRD4 | |
| SCHEMBL31681377 | 0.80 | EIF2AK2 (0.54) | PKMTP53LMNAMAPTBRD4 | |
| SCHEMBL6986758 | 0.79 | PKM (0.56) | PKMTP53LMNAMAPTBRD4 | |
| SCHEMBL6985319 | 0.79 | CA12 (0.53) | PKMTP53LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0991624-B1 | PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT | BOEHRINGER INGELHEIM PHARMA (DE) | 2003-11-19 | — | — | EP | disclosed |
| US-6300342-B1 | FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION | BOEHRINGER INGELHEIM PHARM KG (DE) | 2001-10-09 | — | — | US | disclosed |
| EP-0991624-A1 | PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT | Boehringer Ingelheim Pharma KG (DE) | 2000-04-12 | — | — | EP | disclosed |
| WO-1999000371-A1 | PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT | BOEHRINGER INGELHEIM PHARMA KG (DE) | 1999-01-07 | — | — | WO | disclosed |